| Richard S Urbanski, MD | |
|
2825 E Barnett Rd, Medford, OR 97504-8332 | |
| (541) 789-7000 | |
| Not Available |
| Full Name | Richard S Urbanski |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 2825 E Barnett Rd, Medford, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245307651 | NPI | - | NPPES |
| 027839 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD15696 (Oregon) | Primary |
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093976243 PECOS PAC ID: 3476450560 Enrollment ID: O20031217000186 |
News Archive
A pioneering study carried out among patients in remission from Rheumatoid Arthritis has determined that they display significantly higher temperatures than healthy individuals.
As a tool for controlling the spread of COVID-19, mobile applications for contact tracing are most effective when they are widely adopted and left on indefinitely.
A hand and respiratory hygiene program including frequent use of alcohol-based hand sanitizer helps reduce illness caused by influenza A and missed school days in elementary school children, reports a study in the November issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, announced the allowance of a Japanese patent relating to a technology for the treatment of brain cancer for which the Company holds an exclusive, worldwide license.
NovaBay Pharmaceuticals, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office on a patent application for a broad portfolio of anti-infective compounds, including NVC-612. The patent will broaden protection for NovaBay's first-in-class Aganocide family of compounds, which are designed to fight infections without causing drug resistance.
› Verified 7 days ago
| Entity Name | Asante |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770587107 PECOS PAC ID: 0547177321 Enrollment ID: O20031219000238 |
News Archive
A pioneering study carried out among patients in remission from Rheumatoid Arthritis has determined that they display significantly higher temperatures than healthy individuals.
As a tool for controlling the spread of COVID-19, mobile applications for contact tracing are most effective when they are widely adopted and left on indefinitely.
A hand and respiratory hygiene program including frequent use of alcohol-based hand sanitizer helps reduce illness caused by influenza A and missed school days in elementary school children, reports a study in the November issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, announced the allowance of a Japanese patent relating to a technology for the treatment of brain cancer for which the Company holds an exclusive, worldwide license.
NovaBay Pharmaceuticals, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office on a patent application for a broad portfolio of anti-infective compounds, including NVC-612. The patent will broaden protection for NovaBay's first-in-class Aganocide family of compounds, which are designed to fight infections without causing drug resistance.
› Verified 7 days ago
| Entity Name | Asante Three Rivers Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801891809 PECOS PAC ID: 9931197993 Enrollment ID: O20040506000367 |
News Archive
A pioneering study carried out among patients in remission from Rheumatoid Arthritis has determined that they display significantly higher temperatures than healthy individuals.
As a tool for controlling the spread of COVID-19, mobile applications for contact tracing are most effective when they are widely adopted and left on indefinitely.
A hand and respiratory hygiene program including frequent use of alcohol-based hand sanitizer helps reduce illness caused by influenza A and missed school days in elementary school children, reports a study in the November issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, announced the allowance of a Japanese patent relating to a technology for the treatment of brain cancer for which the Company holds an exclusive, worldwide license.
NovaBay Pharmaceuticals, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office on a patent application for a broad portfolio of anti-infective compounds, including NVC-612. The patent will broaden protection for NovaBay's first-in-class Aganocide family of compounds, which are designed to fight infections without causing drug resistance.
› Verified 7 days ago
| Entity Name | Asante Ashland Community Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730628827 PECOS PAC ID: 7012286859 Enrollment ID: O20180426001620 |
News Archive
A pioneering study carried out among patients in remission from Rheumatoid Arthritis has determined that they display significantly higher temperatures than healthy individuals.
As a tool for controlling the spread of COVID-19, mobile applications for contact tracing are most effective when they are widely adopted and left on indefinitely.
A hand and respiratory hygiene program including frequent use of alcohol-based hand sanitizer helps reduce illness caused by influenza A and missed school days in elementary school children, reports a study in the November issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, announced the allowance of a Japanese patent relating to a technology for the treatment of brain cancer for which the Company holds an exclusive, worldwide license.
NovaBay Pharmaceuticals, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office on a patent application for a broad portfolio of anti-infective compounds, including NVC-612. The patent will broaden protection for NovaBay's first-in-class Aganocide family of compounds, which are designed to fight infections without causing drug resistance.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard S Urbanski, MD 100 E Main St, Suite C, Medford, OR 97501-6041 Ph: () - | Richard S Urbanski, MD 2825 E Barnett Rd, Medford, OR 97504-8332 Ph: (541) 789-7000 |
News Archive
A pioneering study carried out among patients in remission from Rheumatoid Arthritis has determined that they display significantly higher temperatures than healthy individuals.
As a tool for controlling the spread of COVID-19, mobile applications for contact tracing are most effective when they are widely adopted and left on indefinitely.
A hand and respiratory hygiene program including frequent use of alcohol-based hand sanitizer helps reduce illness caused by influenza A and missed school days in elementary school children, reports a study in the November issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, announced the allowance of a Japanese patent relating to a technology for the treatment of brain cancer for which the Company holds an exclusive, worldwide license.
NovaBay Pharmaceuticals, Inc. announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office on a patent application for a broad portfolio of anti-infective compounds, including NVC-612. The patent will broaden protection for NovaBay's first-in-class Aganocide family of compounds, which are designed to fight infections without causing drug resistance.
› Verified 7 days ago
James Benton, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 781 Black Oak Dr, Suite 102, Medford, OR 97504 Phone: 541-789-4236 Fax: 541-789-5965 | |
Ashley R Laird, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2825 E Barnett Rd, Medford, OR 97504 Phone: 541-789-7000 Fax: 310-782-1763 | |
Dr. Peter Canning, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2825 East Barnett Road, Rm 1c026, Medford, OR 97504 Phone: 541-789-7000 | |
Dr. Ryan Garrett, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 Crater Lake Ave, Medford, OR 97504 Phone: 503-215-4323 Fax: 503-215-0297 | |
Mrs. Alicia L Welder, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2825 E Barnett Rd, Medford, OR 97504 Phone: 541-789-7000 | |
Dr. Douglas S Shields, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 Crater Lake Ave, Medford, OR 97504 Phone: 503-215-4323 Fax: 503-215-0297 |